Details of the Drug
General Information of Drug (ID: DMADQL2)
| Drug Name |
Anti-HER-2 mab-FcgR2- FcgR4 fusion proteins
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Recombinant fusion proteins (cancer), Iterative therapeutics; Anti-HER2 mAb analogs (cancer),Iterative therapeutics; Anti-HER-2 mAb-FcgR2- FcgR4 fusion proteins (cancer); Anti-HER-2 mAb-FcgR2-FcgR4 fusion proteins (cancer), Iterative
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Monoclonal antibody
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||